Mukul Aggarwal
- Hematology top 10%
- Acute Myeloid Leukemia Research 7
- Blood groups and transfusion 5
- Multiple Myeloma Research and Treatments 4
-
- Chronic Lymphocytic Leukemia Research 6
-
- COVID-19 Clinical Research Studies 5
-
- COVID-19 and healthcare impacts 5
-
- Lymphoma Diagnosis and Treatment 5
-
- Erythrocyte Function and Pathophysiology 4
- Co-authors
- Manoranjan MahapatraJasmita DassDinesh BhuraniSeema TyagiNarendra AgrawalAbhishek PurohitHara Prasad PatiTulika Seth
- Partner nations
- IndiaUnited StatesSouth Korea
In The Last Decade
Mukul Aggarwal
50 papers receiving 273 citations
Peers
Comparison fields: 5 of 70
- Hematology 80
- Genetics 43
- Infectious Diseases 69
- Molecular Medicine 12
- Internal Medicine 8
Countries citing papers authored by Mukul Aggarwal
This map shows the geographic impact of Mukul Aggarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mukul Aggarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mukul Aggarwal more than expected).
Fields of papers citing papers by Mukul Aggarwal
This network shows the impact of papers produced by Mukul Aggarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mukul Aggarwal. The network helps show where Mukul Aggarwal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mukul Aggarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 5 | |
| 9 | 2019 | 4 | |
| 10 | 2019 | 3 | |
| 11 | 2017 | 2 | |
| 12 | 2017 | 11 | |
| 13 | 2015 | 1 | |
| 14 | 2015 | 7 | |
| 15 | 2014 | 0 | |
| 16 | 2014 | 3 | |
| 17 | 2014 | 12 | |
| 18 | 2013 | 1 | |
| 19 | 2012 | 4 | |
| 20 | 2010 | 4 |
About Mukul Aggarwal
Mukul Aggarwal is a scholar working on Hematology, Genetics and Oncology, having authored 66 papers that have together received 277 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), COVID-19 Clinical Research Studies (5 papers), COVID-19 and healthcare impacts (5 papers), Blood groups and transfusion (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Erythrocyte Function and Pathophysiology (4 papers). The work is most often cited by research in Hematology (80 citations), Genetics (43 citations) and Infectious Diseases (69 citations). Mukul Aggarwal has collaborated with scholars based in India, United States and South Korea. Frequent co-authors include Manoranjan Mahapatra, Jasmita Dass, Dinesh Bhurani, Seema Tyagi, Narendra Agrawal, Abhishek Purohit, Hara Prasad Pati, Tulika Seth, Rishi Dhawan and Renu Saxena.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.